These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 24924742)
21. Pharmacological treatment of persistent atrial fibrillation in the older adult: evidence-based practice. Stanley JM J Am Acad Nurse Pract; 2011 Mar; 23(3):120-6. PubMed ID: 21355944 [TBL] [Abstract][Full Text] [Related]
22. Rate control in atrial fibrillation: looking beyond the average heart rate. Ahmad K; Dorian P Curr Opin Cardiol; 2006 Mar; 21(2):88-93. PubMed ID: 16470141 [TBL] [Abstract][Full Text] [Related]
23. Atrial fibrillation: rhythm control offers no advantage over rate control for some, but not all. Li YB; Hu CL; Liu J; Chen YX; Qu Z; Xu JL; Chen JB; Wan J; Tang QZ; Huang CX Med Hypotheses; 2007; 69(1):206-8. PubMed ID: 17011138 [TBL] [Abstract][Full Text] [Related]
24. The influence of depression and anxiety symptoms on health-related quality of life in patients with atrial fibrillation and atrial flutter. Akintade BF; Chapa D; Friedmann E; Thomas SA J Cardiovasc Nurs; 2015; 30(1):66-73. PubMed ID: 24165697 [TBL] [Abstract][Full Text] [Related]
25. Accuracy of patient perception of their prevailing rhythm: a comparative analysis of monitor data and questionnaire responses in patients with atrial fibrillation. Garimella RS; Chung EH; Mounsey JP; Schwartz JD; Pursell I; Gehi AK Heart Rhythm; 2015 Apr; 12(4):658-65. PubMed ID: 25595926 [TBL] [Abstract][Full Text] [Related]
27. Rate versus rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III Trial. Williams ES; Thompson VP; Chiswell KE; Alexander JH; White HD; Ohman EM; Al-Khatib SM Cardiol J; 2013; 20(4):439-46. PubMed ID: 23913464 [TBL] [Abstract][Full Text] [Related]
28. Is health-related quality of life a predictor of hospitalization or mortality among women or men with atrial fibrillation? Chapa DW; Akintade B; Schron E; Friedmann E; Thomas SA J Cardiovasc Nurs; 2014; 29(6):555-64. PubMed ID: 24165699 [TBL] [Abstract][Full Text] [Related]
29. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial. Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492 [TBL] [Abstract][Full Text] [Related]
30. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Curtis AB; Gersh BJ; Corley SD; DiMarco JP; Domanski MJ; Geller N; Greene HL; Kellen JC; Mickel M; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG; Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747 [TBL] [Abstract][Full Text] [Related]
31. Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Paquette M; Roy D; Talajic M; Newman D; Couturier A; Yang C; Dorian P Am J Cardiol; 2000 Oct; 86(7):764-8. PubMed ID: 11018197 [TBL] [Abstract][Full Text] [Related]
32. Quality of life in patients with atrial fibrillation: how to assess it and how to improve it. Aliot E; Botto GL; Crijns HJ; Kirchhof P Europace; 2014 Jun; 16(6):787-96. PubMed ID: 24469433 [TBL] [Abstract][Full Text] [Related]
33. Treatment of atrial fibrillation. Bajpai A; Savelieva I; Camm AJ Br Med Bull; 2008; 88(1):75-94. PubMed ID: 19059992 [TBL] [Abstract][Full Text] [Related]
34. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. Dagres N; Nieuwlaat R; Vardas PE; Andresen D; Lévy S; Cobbe S; Kremastinos DT; Breithardt G; Cokkinos DV; Crijns HJ J Am Coll Cardiol; 2007 Feb; 49(5):572-7. PubMed ID: 17276181 [TBL] [Abstract][Full Text] [Related]
35. Association between the quality of life and asymptomatic episodes of paroxysmal atrial fibrillation in the J-RHYTHM II study. Yamamoto M; Watanabe E; Suzuki T; Yamazaki T; Ohtsu H; Ozaki Y; Ogawa S; Yamashita T; J Cardiol; 2014 Jul; 64(1):64-9. PubMed ID: 24373865 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic evaluation and follow-up of patients with atrial fibrillation. Dillon P; Ghanbari H Cardiol Clin; 2014 Nov; 32(4):507-19. PubMed ID: 25443233 [TBL] [Abstract][Full Text] [Related]
37. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy. Chung MK; Shemanski L; Sherman DG; Greene HL; Hogan DB; Kellen JC; Kim SG; Martin LW; Rosenberg Y; Wyse DG; J Am Coll Cardiol; 2005 Nov; 46(10):1891-9. PubMed ID: 16286177 [TBL] [Abstract][Full Text] [Related]
38. Self-reported sleep quality of patients with atrial fibrillation and the effects of cardioversion on sleep quality. Kayrak M; Gul EE; Aribas A; Akilli H; Alibasiç H; Abdulhalikov T; Yildirim O; Yazici M; Ozdemir K Pacing Clin Electrophysiol; 2013 Jul; 36(7):823-9. PubMed ID: 23437796 [TBL] [Abstract][Full Text] [Related]
39. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial. Walfridsson H; Walfridsson U; Nielsen JC; Johannessen A; Raatikainen P; Janzon M; Levin LA; Aronsson M; Hindricks G; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Hansen PS Europace; 2015 Feb; 17(2):215-21. PubMed ID: 25567068 [TBL] [Abstract][Full Text] [Related]